FindTrial
Sign In

Study of antimicrobial usage in the ICU admitted patients of different departments of the Mahatma Gandhi medical college and hospital.

Analysis of antimicrobial usage in the IPD-ICU patients of different departments of the hospital as a part of Antimicrobial Stewardship programme.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052739
Enrollment
600
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B95- Streptococcus, Staphylococcus, andEnterococcus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Mahatma Gandhi Medical College and Hospital,Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ALL ICU ADMITTED PATIENTS IN DIFFERENT DEPARTMENTS OF THE HOSPITAL BOTH MEDICAL AND SURGICAL. 2. ALL ICU PATIENTS RECEIVING ANTIMICROBIAL.

Exclusion criteria

Exclusion criteria: 1. ICU ADMITTED PATIENT OF 1 DAY STAY ONLY. 2. ALL ICU PATIENTS NOT RECEIVING ANTIMICROBIAL. 3. PATIENT WHO TOOK DISCHARGE ON REQUEST FROM ICU.

Design outcomes

Primary

MeasureTime frame
1. NUMBER OF CULTURE SAMPLES SENT BEFORE STARTING THE ANTIMICROBIAL. 2. TO FIND THE PERCENTAGE OF RESTRICTED ANTIMICROBIAL BEING USED. 3.ANALYSIS OF INDICATION FOR USING ANTIMICROBIAL 4.ANALYSIS OF ANTIMICROBIAL DOSE - OPTIMISATION. 5.ANALYSIS OF ESCALATION AND DE-ESCALATION OF ANTIMICROBIAL. 6.MONITORING OF IV TO ORAL SWITCH OF ANTIMICROBIAL. 7.ANALYSIS OF LENGTH OF ANTIMICROBIAL THERAPY. Timepoint: ONE YEAR.—

Secondary

MeasureTime frame
1.MONITORING OF ADVERSE DRUG REACTIONS RELATED TO ANTIMICROBIAL.Timepoint: ONE YEAR—

Countries

India

Contacts

Public ContactDr Vinay Kumar Gupta

Mahatma Gandhi Medical College and Hospital

vinay_dr24@yahoo.com09829202820

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026